Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.21.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Accounts payable:      
Clinical and regulatory expenses $ 279 $ 232  
Professional fees 1,347 1,183  
Selling expenses 1,068 1,303  
Manufacturing costs 6,369 4,541  
Other vendors 264 18  
Total accounts payable 9,327 7,277  
Accrued interest payable, related parties 173 42  
Accrued interest payable 462 991  
Accrued expenses:      
Payroll expenses 868 891  
Government rebates and other rebates 1,723 1,355  
Due to EJ Holdings 347 238  
Other accrued expenses 309 704  
Total accrued expenses 3,247 3,188  
Total accounts payable and accrued expenses $ 13,209 $ 11,498 $ 10,697